Development and validation of an oxidative phosphorylation based prognostic model revealing tumor progression and immune microenvironment in lung adenocarcinoma.
Saved in:
| Title: | Development and validation of an oxidative phosphorylation based prognostic model revealing tumor progression and immune microenvironment in lung adenocarcinoma. |
|---|---|
| Authors: | Ma H; Department of Respiratory, The Fourth Affiliated Hospital of Xinjiang Medical University, Urumqi, 830000, Xinjiang, China., Zeng S; Department of Cardiothoracic Surgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, 365000, Fujian, China., Xie C; Department of Cardiothoracic Surgery, The Second People's Hospital of Qinzhou, Qinzhou, 535099, Guangxi, China., Gao C; Hangzhou Astrocyte Technology Co,.Ltd., Hangzhou, 311100, China., Jiang S; Hangzhou Astrocyte Technology Co,.Ltd., Hangzhou, 311100, China., Chen L; Hangzhou Astrocyte Technology Co,.Ltd., Hangzhou, 311100, China., Tian W; Hangzhou Astrocyte Technology Co,.Ltd., Hangzhou, 311100, China., Huang L; Department of Thoracic Surgery, Shenzhen Baoan People's Hospital, Shenzhen, 518100, Guangdong, China. 452955561@qq.com. |
| Source: | Discover oncology [Discov Oncol] 2026 Feb 11; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04478-3 |
